Article
Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice.
Antimicrobial agents and chemotherapy - 1 Apr 2003
Marsollier Laurent, Honoré Nadine, Legras Pierre, Manceau Anne Lise, Kouakou Henri, Carbonnelle Bernard, Cole Stewart T
Abstract excerpt
By use of a murine model for Buruli ulcer, Mycobacterium ulcerans was found to be susceptible to rifampin, with the MIC being 0.5 to 1 micro g/ml. Three mutants were isolated after rifampin monotherapy. Two were resistant to rifampin at 8 micro g/ml, and one was resistant to rifampin at 32 micro g/ml. The mutants harbored Ser416Phe mutations and His420Tyr mutations in the rpoB gene, and these mutations have also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
